Mechanical Engineering Professor Alan McGaughey of Carnegie Mellon University recently coordinated the Phonon Olympics, ...
With new phase 3 data backing the ability of its emergency use zalunfiban to fend off further heart damage, CeleCor ...
Plus, a new program to help nonprofits learn tech tools, Pennsylvania announces an AI partnership with Penn and more Philly power moves.
Medpage Today on MSN
Daily PCSK9 Pill Reduces Cholesterol When Statins Aren't Cutting It
NEW ORLEANS -- The investigational oral PCSK9 inhibitor enlicitide reduced low-density lipoprotein (LDL) cholesterol in ...
Smithsonian Magazine on MSN
New Daily Pill Could Potentially Be Life-Saving for Americans With High Cholesterol Levels, Researchers Say
The medication, which significantly lowers the risk of heart attacks, could be a promising alternative to expensive and ...
Among people with a previous heart attack or stroke, or who are at high risk for one, a daily oral medication may offer an effective alternative to injections of PCSK9 inhibitors to lower low-density ...
Merck’s pill, which could be the first oral PCSK9 drug to get to market, displayed similar effects on lipid levels as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback